We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.

For more information visit our privacy policy.

TREATMENT PROTOCOL Sample Clauses

TREATMENT PROTOCOL. The Contractor shall be responsible for positively identifying all target species before they are cut or herbicide applied. Failure to do so may incur unnecessary damage done to the DISTRICT, and shall be repaired or replanted at the Contractor’s expense. Any replacement materials are subject to DISTRICT’s approval.
Sample 1Sample 2Sample 3
TREATMENT PROTOCOL. The clinical pharmacist will apply nationally recognized evidence-based treatment guidelines, as well as up to date clinical research information when providing hypertension management services. The following treatment guideline(s) and resources will be utilized to help direct the treatment of patients.
Sample 1Sample 2
TREATMENT PROTOCOL. The clinical pharmacist will apply nationally recognized evidence-based treatment guidelines, as well as up to date clinical research information when providing diabetes management services. The following treatment guideline(s) and resources will be utilized to help direct the treatment of patients. 2020 American Diabetes Association Standards of Medical Care in Diabetes 2020 Consensus Statement by the Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm From those guidelines, the pharmacist will use the following guiding principles for management of diabetes mellitus. These principles are not binding, and the pharmacist may deviate from what is outlined below based on an individual patient’s clinical situation. If deviations are made, the pharmacist will document rationale in the patient chart.
Sample 1
TREATMENT PROTOCOL. A. JBCT is an intensive, milieu-based treatment program that quickly facilitates competency through a combination of group and individual therapy. B. Group therapy is central to the restoration process, and Contractor shall provide treatment daily to male Patient Inmates. Group content should include one of the four group treatment domains: competency education, understanding and management of mental illness, physical exercise, and mental/social stimulation. Many group topics can be assimilated into the groupings, e.g., mock trial, music-based competency treatment, etc. C. Contractor shall provide individual sessions per day to each male Patient Inmate. Individual sessions may be used to check-in with male Patient Inmates and/or discuss key legal elements of the individual’s case that may be too sensitive for group discussion. Specific competency issues can best be addressed individually, e.g., a Patient Inmate understands court proceedings but struggles to apply the knowledge to their individual case. D. Contractor’s psychiatrist shall see each male Patient Inmate weekly. A psychiatric assessment is a component of the admission process, and more frequent appointments shall be available as needed. E. Together on a weekly basis, the multi-disciplinary treatment team shall review: i. Progress of all male Patient Inmates admitted within 30 days, ii. At subsequent 14-day intervals thereafter, and iii. When a male Patient Inmate is under consideration for discharge. The multi-disciplinary treatment team shall be responsible for providing the committing court progress reports pursuant to Penal Code section 1370 subdivision (b)(1). 0800-0830 Staff Morning Meeting Check In, Case Management Get Inmates Out & Ready 0800-0830 Staff Morning Meeting Check In, Case Management Get Inmates Out & Ready 0800-0830 Staff Morning Meeting Check In, Case Management Get Inmates Out & Ready 0800-0830 Staff Morning Meeting Check In, Case Management Get Inmates Out & Ready 0800-0830 Staff Morning Meeting Check In, Case Management Get Inmates Out & Ready 0830-0900 Morning Intentions & Goal Setting 0830-0900 Morning Intentions & Goal Setting 0830-0900 Morning Intentions & Goal Setting 0830-0900 Morning Intentions & Goal Setting 0830-0900 Morning Intentions & Goal Setting 0900-1000 Psycho-educational Group 0900-1000 Clinical Process Group 0900-1000 Psycho-educational Group 0900-1000 Psycho-educational Group 0900-1000 Psycho-educational Group (Bingo) 1000-1030 Lunch Break 1000-1030 Lunc...
Sample 1
TREATMENT PROTOCOL. CTTC will provide the list of Objectives and Goals, the Calmare(R) Tutorial & Study Guide, Calmare(R) Treatment Protocol and the User's Manual for the MC-5A, or equivalent Calmare(R) device. Upon successful completion the participant will be awarded a Calmare(R) Scrambler MC-5A User Certificate. CTT8K41924 SCHEDULE 12 COUNTRY/ COUNTRIES IN ASSIGNED TERRITORY ITALY MALTA CTT8K41925 SCHEDULE 13 PRICING
Sample 1
TREATMENT PROTOCOL. Omrix shall provide to FFF in a timely manner any information in Omrix's possession about the Investigational Drug that is necessary for FFF to prepare the Treatment Protocol, including without limitation technical, pre-clinical, clinical, and information regarding the Manufacturing Specifications. Omrix shall provide FFF with feedback in a timely manner on drafts of the Treatment Protocol.
Sample 1
TREATMENT PROTOCOL. FFF shall prepare a treatment protocol ("Treatment Protocol") in consultation with and information provided by Omrix and in accordance with 21 CFR Section 312.35(a) to use the Investigational Drug to treat patients with primary immune deficiency who are not enrolled as subjects in the Clinical Trials. FFF has been engaged in discussions with the FDA regarding the Treatment Protocol and shall continue to be responsible for negotiating the terms of the Treatment Protocol with the FDA. FFF shall prepare the Treatment Protocol in time for FFF to submit it to the FDA immediately after initiation of the Phase 2 Clinical Trial with the goal of obtaining approval during or immediately after the conclusion of the Phase 2 Clinical Trial. FFF shall be the sponsor of the Treatment Protocol and shall submit the Treatment Protocol to the FDA under the FFF IND. In addition, FFF will provide Omrix with an electronic copy of the packaging material which will be used in the Treatment Protocol consistent with all FDA requirements.
Sample 1
TREATMENT PROTOCOL. FFF shall be responsible for obtaining a Treatment Protocol, as defined in section 1.26, under the FFF IND and in accordance with the provisions of this section 5.1.
Sample 1
TREATMENT PROTOCOL. A. JBCT is an intensive, milieu-based treatment program that quickly facilitates competency through a combination of group and individual therapy. B. Group therapy is central to the restoration process, and CONTRACTOR shall provide treatment daily to male Patient Inmates. Group content should include one of the four group treatment domains: competency education, understanding and management of mental illness, physical exercise, and mental/social stimulation. Many group topics can be assimilated into the groupings, e.g., mock trial, music-based competency treatment, etc. C. CONTRACTOR shall provide individual sessions per day to each male Patient Inmate. Individual sessions may be used to check-in with male Patient Inmates and/or discuss key legal elements of the individual’s case that may be too sensitive for group discussion. Specific competency issues can best be addressed individually, e.g., a Patient Inmate understands court proceedings but struggles to apply the knowledge to their individual case. D. CONTRACTOR’s psychiatrist shall see each male Patient Inmate weekly. A psychiatric assessment is a component of the admission process, and more frequent appointments shall be available as needed. E. Together on a weekly basis, the multi-disciplinary treatment team shall review: i. Progress of all male Patient Inmates admitted within 30 days, ii. At subsequent 14-day intervals thereafter, and iii. When a male Patient Inmate is under consideration for discharge. The multi-disciplinary treatment team shall be responsible for providing the committing court progress reports pursuant to Penal Code section 1370 subdivision (b)(1).
Sample 1

Related to TREATMENT PROTOCOL

  • Substance Abuse Treatment Information Substance abuse treatment information shall be maintained in compliance with 42 C.F.R. Part 2 if the Party or subcontractor(s) are Part 2 covered programs, or if substance abuse treatment information is received from a Part 2 covered program by the Party or subcontractor(s).

  • Protocol No action to coerce or censor or penalize any negotiation participant shall be made or implied by any other member as a result of participation in the negotiation process.

  • Emergency Medical Treatment I grant the Releasees permission to authorize emergency medical treatment as they deem appropriate, and agree that such action by the Releasees shall be subject to the terms of this Agreement. I understand and agree that the Releasees assume no responsibility for any injury or damage that might result from such emergency medical treatment.

  • National Treatment and Most-favoured-nation Treatment (1) Each Contracting Party shall accord to investments of investors of the other Contracting Party, treatment which shall not be less favourable than that accorded either to investments of its own or investments of investors of any third State. (2) In addition, each Contracting Party shall accord to investors of the other Contracting Party, including in respect of returns on their investments, treatment which shall not be less favourable than that accorded to investors of any third State. (3) The provisions of paragraphs (1) and (2) above shall not be construed so as to oblige one Contracting Party to extend to the investors of the other the benefit of any treatment, preference or privilege resulting from: (a) Any existing or future free trade area, customs unions, monetary union or similar international agreement or other forms of regional cooperation to which one of the Contracting Parties is or may become a party, or (b) Any matter pertaining wholly or mainly to taxation.

  • Signaling protocol 4.1.3.1 SS7 Signaling is AT&T-21STATE’s preferred method for signaling. Where MF signaling is currently used, the Parties agree to use their best efforts to convert to SS7. If SS7 services are provided by AT&T-21STATE, they will be provided in accordance with the provisions of the applicable access tariffs. 4.1.3.2 Where MF signaling is currently used, the Parties agree to interconnect their networks using MF or dual tone MF (DTMF) signaling, subject to availability at the End Office Switch or Tandem Switch at which Interconnection occurs. The Parties acknowledge that the use of MF signaling may not be optimal. AT&T-21STATE will not be responsible for correcting any undesirable characteristics, service problems or performance problems that are associated with MF/SS7 inter-working or the signaling protocol required for Interconnection with CLEC employing MF signaling.

  • Determination of Responsiveness 28.1 The Procuring Entity's determination of a Tender's responsiveness is to be based on the contents of the Tender itself, as defined in ITT28.2.

  • Prescription Drug Plan Retail and mail order prescription drug copays for bargaining unit employees shall be as follows:

  • Medical Treatment Undersigned understands that the Released Parties do not have medical personnel available at the location of the activities. Undersigned hereby grants the Released Parties permission to administer first aid or to authorize emergency medical treatment, if necessary. Undersigned understands and agrees that any such action by the Released Parties shall be subject to the terms of this agreement and release, including any liability arising from the negligence of the Released Parties when administering first aid or authorizing others to do so. Undersigned understands and agrees that the Released Parties do not assume responsibility for any injury or damage which might arise out of or in connection with such authorized emergency medical treatment.

  • Xxx Treatment We have not promised you any particular tax outcome from buying or holding the Note.

  • Future Treatment of Unallowable Costs Unallowable Costs shall be separately determined and accounted for by Defendants, and Defendants shall not charge such Unallowable Costs directly or indirectly to any contracts with the United States or any State Medicaid program, or seek payment for such Unallowable Costs through any cost report, cost statement, information statement, or payment request submitted by Defendants or any of their subsidiaries or affiliates to the Medicare, Medicaid, TRICARE, or FEHBP Programs.

Most Referenced Clauses

Most Referenced Definitions